Newronika’s AlphaDBS System Earns CE Mark in Europe

Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system being evaluated in patients with Parkinson’s disease, has received CE Mark approval in Europe. The CE Mark is a seal of approval issued by the European Commission that means products have been assessed to meet pre-established safety, health,…

Newronika’s AlphaDBS System Implanted in First Patient

The first Parkinson’s disease patient has been implanted with Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system, in a clinical trial conducted in Italy and Poland. DBS is an established treatment for people with Parkinson’s disease who do not respond adequately to medication. It is a surgical procedure…